CalciMedica, Inc. (CALC) income statement
CALCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 1/30
$1.17−0.05 (-4.10%)
Close on Nov 18, 2026Market cap $39.95MP/E –Yield –
CalciMedica, Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, FY
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity, FY2025
- -761.0%
Financial strength
- Current ratio
- 5.58
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 533.4%
Valuation
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 7.25
- Dividend yield
- –
See a number that looks wrong?